Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-19
2011-04-19
Anderson, James D (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S255060, C514S254110
Reexamination Certificate
active
07928138
ABSTRACT:
The invention is the discovery of an actinomycete genus, given the nameSalinosporagen. nov., that displays an obligate requirement of seawater (Na+) for growth and unique 16S rRNA signature nucleotides. The invention is also the use of the genus for the production and discovery of active biomolecules such as pharmaceutical agents, agrichemicals, immunomodifiers, enzymes and enzyme inhibitors.
REFERENCES:
patent: 5445829 (1995-08-01), Paradissis et al.
patent: 5576012 (1996-11-01), Bauer et al.
patent: 5601845 (1997-02-01), Buxton et al.
patent: 5641515 (1997-06-01), Ramtoola
patent: 5653987 (1997-08-01), Modi et al.
patent: 5654286 (1997-08-01), Hostetler
patent: 5667809 (1997-09-01), Trevino et al.
patent: 5683676 (1997-11-01), Akehurst et al.
patent: 5688529 (1997-11-01), Lidgate et al.
patent: 5707615 (1998-01-01), Cardin et al.
patent: 5707641 (1998-01-01), Gertner et al.
patent: 5726181 (1998-03-01), Hausheer et al.
patent: 5733888 (1998-03-01), Carver et al.
patent: 5756764 (1998-05-01), Fenteany et al.
patent: 5874443 (1999-02-01), Kiely et al.
patent: 5886210 (1999-03-01), Rayle et al.
patent: 5922683 (1999-07-01), Or et al.
patent: 6133308 (2000-10-01), Soucy et al.
patent: 6147223 (2000-11-01), Fenteany et al.
patent: 6214862 (2001-04-01), Fenteany et al.
patent: 6294560 (2001-09-01), Soucy et al.
patent: 6333358 (2001-12-01), Nakazato et al.
patent: 6335358 (2002-01-01), Fenteany et al.
patent: 6350759 (2002-02-01), Casara et al.
patent: 6458825 (2002-10-01), Fenteany et al.
patent: 6500825 (2002-12-01), Lan et al.
patent: 6506787 (2003-01-01), Fujishita et al.
patent: 6509331 (2003-01-01), Audia et al.
patent: 6566553 (2003-05-01), Soucy et al.
patent: 6645999 (2003-11-01), Schreiber et al.
patent: 6794516 (2004-09-01), Soucy et al.
patent: 6838477 (2005-01-01), Schreiber et al.
patent: 6849743 (2005-02-01), Soucy et al.
patent: 7144723 (2006-12-01), Fenical et al.
patent: 7176232 (2007-02-01), Fenical et al.
patent: 7176233 (2007-02-01), Fenical et al.
patent: 7572606 (2009-08-01), Lam et al.
patent: 2001/0002391 (2001-05-01), Brand et al.
patent: 2001/0051654 (2001-12-01), Elliott et al.
patent: 2003/0157695 (2003-08-01), Fenical et al.
patent: 2004/0138196 (2004-07-01), Fenical et al.
patent: 2006/0008852 (2006-01-01), Fenical et al.
patent: 2009/0197937 (2009-08-01), Fenical et al.
patent: 2010/0144826 (2010-06-01), Fenical et al.
patent: 2429163 (2002-06-01), None
patent: WO 96/32105 (1996-10-01), None
patent: WO 99/09006 (1999-02-01), None
patent: WO 99/15183 (1999-04-01), None
patent: WO 00/23614 (2000-04-01), None
patent: WO 02/47610 (2002-06-01), None
patent: WO 2004/071382 (2004-08-01), None
patent: WO 2005/003137 (2005-01-01), None
Fenical et al. Powerpoint Presentation, Center for Marine Biotechnology and Biomedicine, Jun. 24, 2001.
Bernan et al., “Marine Microorganisms as a Source of New Natural Products”,Advances in Applied Microbiology, 43:57-90 (1997).
Blunt et al., “Marine Natural Products”,Nat. Prod. Rep., 20:1-48 (2003).
Bull et al., “Search and Discovery Strategies for Biotechnology: The Paradigm Shift”,Microbiology and Molecular Biology Reviews, 64:573-606 (Sep. 2000).
Cheng et al., “Arenaric Acid, a New Pentacyclic Polyether Produced by a Marine Bacterium (Actinomycetales)”,J. Nat. Prod., 62:605-607 (1999).
Cheng et al., “Luisols A and B, New Aromatic Tetraols Produced by an Estuarine Marine Bacterium of the GenusStreptomyces(Actinomycetales)”J Nat. Prod., 62:608-610 (1999).
Colquhoun et al., “Novel Rhodococci and Other Mycolate Actinomycetes from the Deep Sea”,Antonie van Leeuwenhoek, 74:27-40 (1998).
Colquhoun et al., “Taxonomy and Biotransformation Activities of Some Deep-Sea Actinomycetes”,Extremophiles, 2:269-277 (1998).
Davidson, “New Dimensions in Natural Products Research: Cultured Marine Microorganisms”,Current Opinion in Biotechnology, 6:284-291 (1995).
Elliott et al., “Proteasome Inhibition: A New Anti-Inflamatory Strategy”,J. Mol. Med., 81:235-245 (2003).
Erba et al., “Mode of Action of Thiocoraline, a Natural Marine Compound With Anti-tumour Activity”,British Journal of Cancer, 88(7):971-980 (1999).
Feling et al., “Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Noval Microbial Source, a Marine Bacterium of the New GenusSalinospora”, Angew. Chem. Int. Ed., 42(3):355-357 (2003).
Fenical, “Chemical Studies of Marine Bacteria: Developing a New Resource”,Chem. Rev., 93:1673-1683 (1993).
Fenical, “New Pharmaceuticals from Marine Organisms”,Marine Biotechnology, 15:339-341 (1997).
Fenical et al., “Marine Microorganisms as a Developing Resource for Drug Discovery”,Pharmaceutical News, 9:489-494 (2002).
Fernandez-Chimeno et al., “A Novel Cytotoxic Macrolide Produced by a Marine Micromonospora”,Journal of Antibiotics, 53(5):474-478 (2000).
Fusetani (ed.), “Marine Microorganisms and Drug Discovery: Current Status and Future Potential”,Basel, Karger, pp. 6-29 (2000).
Goldberg et al., “Not Just Research Tools—Proteasome Inhibitors Offer Therapeutic Promise”,Nature Medicine, 8(4):338-340 (Apr. 2002).
Goodfellow et al., “Actinomycetes in Biotechnology”, Okami et al., ed.,Search and Discovery of new Antibiotics, Academic Press: San Diego, pp. 33-67 (1988).
Goodfellow et al., “Actinomycetes in Marine Sediments”, Ortiz-Ortiz et al., ed.,Biological, Biochemical and Biomedical Aspects of Actinomycetes, Academic Press: Orlando, pp. 453-472 (1984).
Goodfellow et al., “Search and Discovery of Industrially Significant Actinomycetes”,In Microbial Products: New Approaches, Society for General Microbiology Symposium No. 44 eds Baumberg et al., Cambridge: Cambridge University Press, pp. 343-383 (1989).
Hardt et al., “Neomarinone, and New Cytotoxic Marinone Derivatives, Produced by a Marine Filamentous Bacterium (Actinomycetales)”,Tetrahedron Letters, 14(13):2073-2076 (Mar. 2000).
He et al., “Lomaiviticins A and B, Potent Antitumor Antibiotics fromMicromonospora lomaivitiensis”, J. Am. Chem. Soc., 123:5362-5363 (2001).
Helmke et al., “Rhodococcus marinonascensSp. Nov., An Actinomycete From the Sea”,Int. J Syst. Bacteriol, 34:127-138 (1984).
Horan, “Aerobic Actinomycetes: A Continuing Source of Novel Natural Products”, In Gullo, (ed.),The Discovery of Natural Products With Therapeutic Potential, Boston: Butterworth-Heineman, pp. 1-30 (1994).
Hopwood, “Genetic Manipulation ofStreptomycesPolyketide Synthase Genes For Novel Secondary Metabolite Production”,FEMS Microbiol. Rev., 16:233-234 (1995).
Jenson et al., “Strategies for the Discovery of Secondary Metabolites from Marine Bacteria: Ecological Perspectives”,Annu. Rev. Microbiol., 48:559-584 (1994).
Jensen et al., “The Relative Abundance and Seawater Requirements of Gram Positive Bacteria in Near-Shore Tropical Marine Samples”,Microb. Ecol., 29(3):249-257 (1995).
Joseph et al., “Laboratory Cultivation of Widespread and Previously Uncultured Soil Bacteria”,Appl. Environ. Microbiol. 69(12):7210-7215 (2003).
Koch et al., “16S Ribosomal DNA Analysis of the Genera Micromonospora, Actinoplanes,”Int. Journal of Systematic Bacteriology, 46:765-768 (1996).
Mincer et al., “Widespread and Persistent Populations of a Major New Marine Actinomycete Taxon in Ocean Sediments”,Appl. Eviron. Microbiol., 68(10):5005-5011 (2002).
Moran et al., “Evidence for IndigenousStreptomycesPopulations in a Marine Environment”,Applied and Environmental Microbiology, 61(10):3695-3700 (1995).
Nesternenko et al., “Rhodococcus luteusNom, Nov. andRhodococcus marisNom. Nov.”,Int'l. Journal of Systematic Bacteriology, 32(1):1-14 (1982).
Nicolaus, “Symbiotic Approach to Drug Design”,Decision Making in Drug Research, pp. 173-186 (1983).
Nolan et al., “Isolation an
Feling Robert H. R.
Fenical William
Jensen Paul R.
Mincer Tracy J.
Anderson James D
DLA Piper (LLP) US
Regents of the University of California
LandOfFree
Marine actinomycete taxon for drug and fermentation product... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Marine actinomycete taxon for drug and fermentation product..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marine actinomycete taxon for drug and fermentation product... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660732